|
KR20010082515A
(ko)
|
1998-02-17 |
2001-08-30 |
우에노 도시오 |
아미디노 유도체 및 그 유도체를 유효 성분으로서함유하는 약제
|
|
WO2003026587A2
(en)
*
|
2001-09-26 |
2003-04-03 |
Bristol-Myers Squibb Company |
Compounds useful for treating hepatitus c virus
|
|
AU2003241833A1
(en)
|
2002-05-28 |
2003-12-12 |
Ono Pharmaceutical Co., Ltd. |
Beta-ALANINE DERIVATIVE AND USE THEREOF
|
|
US7820682B2
(en)
|
2002-10-03 |
2010-10-26 |
Ono Pharmaceutical Co., Ltd. |
LPA receptor antagonist
|
|
ATE528276T1
(de)
|
2003-12-19 |
2011-10-15 |
Ono Pharmaceutical Co |
Lysophosphatidylsäurerezeptor-antagonistische verbindungen und ihre anwendungen
|
|
ATE413167T1
(de)
|
2004-08-17 |
2008-11-15 |
Galderma Res & Dev |
Neuartige biaromatische ppar-rezeptoren aktivierende zusammensetzungen und ihre verwendung in kosmetischen oder pharmazeutischen zusammensetzungen
|
|
FR2874379B1
(fr)
|
2004-08-17 |
2006-10-27 |
Galderma Res & Dev |
Nouveaux composes bi-aromatiques activateurs des recepteurs de type ppar et leur utilisation dans des compositions cosmetiques ou pharmaceutiques
|
|
WO2007019397A2
(en)
|
2005-08-05 |
2007-02-15 |
Genelabs Technologies, Inc. |
6-membered aryl and heteroaryl derivatives for the treatment of hepatitis c virus
|
|
GB2466121B
(en)
|
2008-12-15 |
2010-12-08 |
Amira Pharmaceuticals Inc |
Antagonists of lysophosphatidic acid receptors
|
|
GB2474748B
(en)
|
2009-10-01 |
2011-10-12 |
Amira Pharmaceuticals Inc |
Polycyclic compounds as lysophosphatidic acid receptor antagonists
|
|
GB2474120B
(en)
|
2009-10-01 |
2011-12-21 |
Amira Pharmaceuticals Inc |
Compounds as Lysophosphatidic acid receptor antagonists
|
|
AR079022A1
(es)
|
2009-11-02 |
2011-12-21 |
Sanofi Aventis |
Derivados de acido carboxilico ciclico sustituidos con acilamino, su uso como productos farmaceuticos, composicion farmaceutica y metodo de preparacion
|
|
KR20130126659A
(ko)
|
2010-12-07 |
2013-11-20 |
아미라 파마슈티칼스 인코포레이티드 |
리소포스파티드산 수용체 길항제 및 섬유증 치료에서의 그의 용도
|
|
WO2012138648A1
(en)
|
2011-04-06 |
2012-10-11 |
Irm Llc |
Compositions and methods for modulating lpa receptors
|
|
US20130122297A1
(en)
|
2011-10-24 |
2013-05-16 |
Northwestern University |
Molecular gauge blocks for building on the nanoscale
|
|
WO2013070879A1
(en)
|
2011-11-10 |
2013-05-16 |
Bristol-Myers Squibb Company |
Methods for treating spinal cord injury with lpa receptor antagonists
|
|
JP2015520202A
(ja)
|
2012-06-20 |
2015-07-16 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
Ｌｐａｒ拮抗薬としてのｎ−アルキルトリアゾール化合物
|
|
WO2014145873A2
(en)
|
2013-03-15 |
2014-09-18 |
Epigen Biosciences, Inc. |
Heterocyclic compounds useful in the treatment of disease
|
|
EP3013796B9
(en)
|
2013-06-27 |
2020-07-01 |
LG Chem, Ltd. |
Biaryl derivatives as gpr120 agonists
|
|
US10099981B2
(en)
|
2015-03-31 |
2018-10-16 |
University Of Georgia Research Foundation, Inc. |
Methods for meta-arylation of aromatic alcohols
|
|
CA2992889A1
(en)
|
2015-09-04 |
2017-03-09 |
F. Hoffmann-La Roche Ag |
Phenoxymethyl derivatives
|
|
AR108838A1
(es)
|
2016-06-21 |
2018-10-03 |
Bristol Myers Squibb Co |
Ácidos de carbamoiloximetil triazol ciclohexilo como antagonistas de lpa
|
|
WO2019041340A1
(en)
|
2017-09-04 |
2019-03-07 |
Eli Lilly And Company |
LYSOPHOSPHATIDE ACID RECEPTOR 1 RECEPTOR INHIBITORS (LPAR1)
|
|
JP7212047B2
(ja)
|
2017-12-19 |
2023-01-24 |
ブリストル－マイヤーズ スクイブ カンパニー |
Ｌｐａアンタゴニストとしてのシクロヘキシル酸ピラゾールアゾール
|
|
JP7299892B2
(ja)
|
2017-12-19 |
2023-06-28 |
ブリストル－マイヤーズ スクイブ カンパニー |
Ｌｐａアンタゴニストとしてのシクロヘキシル酸ピラゾールアジン
|
|
JP7208240B2
(ja)
|
2017-12-19 |
2023-01-18 |
ブリストル－マイヤーズ スクイブ カンパニー |
Ｌｐａアンタゴニストとしてのシクロヘキシル酸トリアゾールアジン
|
|
EP3728216B1
(en)
|
2017-12-19 |
2023-09-06 |
Bristol-Myers Squibb Company |
Pyrazole n-linked carbamoyl cyclohexyl acids as lpa antagonists
|
|
EP3728209B1
(en)
|
2017-12-19 |
2025-12-24 |
Bristol-Myers Squibb Company |
Cyclohexyl acid isoxazole azines as lpa antagonists
|
|
CN112041302B
(zh)
|
2017-12-19 |
2024-11-19 |
百时美施贵宝公司 |
作为lpa拮抗剂的吡唑o-连接的氨基甲酰基环己基酸
|
|
US11447475B2
(en)
|
2017-12-19 |
2022-09-20 |
Bristol-Myers Squibb Company |
Isoxazole N-linked carbamoyl cyclohexyl acids as LPA antagonists
|
|
US11261180B2
(en)
|
2017-12-19 |
2022-03-01 |
Bristol-Myers Squibb Company |
Cyclohexyl acid isoxazole azoles as LPA antagonists
|
|
CN111712492B
(zh)
|
2017-12-19 |
2024-05-31 |
百时美施贵宝公司 |
作为lpa拮抗剂的环己基酸三唑唑类
|
|
WO2019126084A1
(en)
|
2017-12-19 |
2019-06-27 |
Bristol-Myers Squibb Company |
Isoxazole o-linked carbamoyl cyclohexyl acids as lpa antagonists
|
|
EP3807254A4
(en)
*
|
2018-06-18 |
2022-03-23 |
Epigen Biosciences, Inc. |
HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASES
|
|
ES2946657T3
(es)
|
2018-09-18 |
2023-07-24 |
Bristol Myers Squibb Co |
Acidos ciclopentílicos como antagonistas de LPA
|
|
ES2948793T3
(es)
|
2018-09-18 |
2023-09-19 |
Bristol Myers Squibb Co |
Acidos cicloheptílicos como antagonistas de LPA
|
|
EP3853232B1
(en)
|
2018-09-18 |
2023-03-01 |
Bristol-Myers Squibb Company |
Oxabicyclo acids as lpa antagonists
|
|
CN111434653A
(zh)
|
2019-01-15 |
2020-07-21 |
武汉朗来科技发展有限公司 |
三氮唑类化合物及其制备方法与用途
|
|
CN111434655A
(zh)
|
2019-01-15 |
2020-07-21 |
武汉朗来科技发展有限公司 |
溶血磷脂酸受体拮抗剂及其制备方法
|
|
WO2020257135A1
(en)
|
2019-06-18 |
2020-12-24 |
Bristol-Myers Squibb Company |
Triazole carboxylic acids as lpa antagonists
|
|
EP3986553B1
(en)
|
2019-06-18 |
2026-03-25 |
Bristol-Myers Squibb Company |
Cyclobutyl carboxylic acids as lpa antagonists
|
|
CN114599640A
(zh)
|
2019-06-18 |
2022-06-07 |
百时美施贵宝公司 |
作为lpa拮抗剂的异噁唑羧酸
|
|
PH12022550225A1
(en)
|
2019-07-30 |
2022-12-19 |
Taisho Pharmaceutical Co Ltd |
Urea compound for antagonizing lpa1 receptor
|
|
US20230043672A1
(en)
|
2019-12-12 |
2023-02-09 |
Chiesi Farmaceutici S.P.A. |
Aromatic amido derivatives as lpa receptor 2 inhibitors
|
|
WO2021116257A1
(en)
|
2019-12-12 |
2021-06-17 |
Chiesi Farmaceutici S.P.A. |
Thienopyrimidine derivatives as lpa receptor 2 inhibitors
|
|
WO2022034568A1
(en)
|
2020-08-11 |
2022-02-17 |
Viva Star Biosciences Limited |
Triazole-pyridinyl substituted azacyclohexyl acetic acid compounds as lpa receptor antagonists
|
|
CN116583501A
(zh)
|
2020-10-22 |
2023-08-11 |
罗特斯生物公司 |
用于治疗与lpa受体活性相关的病症的化合物和组合物
|
|
CN114456157A
(zh)
|
2020-11-10 |
2022-05-10 |
武汉人福创新药物研发中心有限公司 |
氮取代氨基碳酸酯噻吩类化合物及其用途
|
|
CN114456159A
(zh)
|
2020-11-10 |
2022-05-10 |
武汉人福创新药物研发中心有限公司 |
氮取代杂环噻吩类化合物及其用途
|
|
CN114621135B
(zh)
|
2020-12-11 |
2024-01-30 |
上海拓界生物医药科技有限公司 |
一种lpa1小分子拮抗剂
|
|
CN117043144A
(zh)
|
2021-03-24 |
2023-11-10 |
奇斯药制品公司 |
作为lpa受体2抑制剂的8-环-取代的喹唑啉衍生物
|
|
JP2024525679A
(ja)
|
2021-07-20 |
2024-07-12 |
上海拓界生物医薬科技有限公司 |
Ｌｐａ１低分子拮抗薬
|
|
EP4419509A4
(en)
|
2021-10-21 |
2025-10-15 |
Lhotse Bio Inc |
COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH LPA RECEPTOR ACTIVITY
|
|
TW202342017A
(zh)
*
|
2022-02-25 |
2023-11-01 |
美商洛子峰生物有限公司 |
用於治療與ｌｐａ受體活性相關的病狀的化合物及組合物
|
|
EP4622713A1
(en)
|
2022-11-24 |
2025-10-01 |
Lhotse Bio, Inc. |
Compounds and compositions for treating conditions associated with lpa receptor activity
|